KODIAK SCIENCES INC. (KOD) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Lose; EPS growth Win.
- 2025-Q3: Total return Win; Revenue growth Lose; EPS growth Lose.
19/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 4 wins, 8 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseKOD / S&P 2.20% / 15.20% |
LoseKOD / S&P KOD unavailable / 15.00% |
LoseKOD / S&P 10.26% / 50.40% |
| 2026-Q11/3 |
WinKOD / S&P 36.34% / -4.33% |
LoseKOD / S&P KOD unavailable / 11.30% |
LoseKOD / S&P 14.88% / 27.70% |
| 2025-Q42/3 |
WinKOD / S&P 70.80% / 2.65% |
LoseKOD / S&P KOD unavailable / 9.00% |
WinKOD / S&P 28.57% / 13.40% |
| 2025-Q31/3 |
WinKOD / S&P 338.87% / 8.12% |
LoseKOD / S&P KOD unavailable / 4.61% |
LoseKOD / S&P 12.88% / 13.45% |
| 2025-Q21/3 |
WinKOD / S&P 32.74% / 10.94% |
LoseKOD / S&P KOD unavailable / 4.83% |
LoseKOD / S&P 1.06% / 10.63% |
| 2025-Q10/3 |
LoseKOD / S&P -71.76% / -4.27% |
LoseKOD / S&P KOD unavailable / 4.98% |
LoseKOD / S&P -18.06% / 10.57% |
| 2024-Q41/3 |
WinKOD / S&P 281.23% / 2.41% |
LoseKOD / S&P KOD unavailable / 5.25% |
LoseKOD / S&P -32.26% / 6.15% |
| 2024-Q31/3 |
WinKOD / S&P 11.06% / 5.89% |
LoseKOD / S&P KOD unavailable / 5.89% |
LoseKOD / S&P -29.54% / 6.11% |
| 2024-Q20/3 |
LoseKOD / S&P -55.32% / 4.28% |
LoseKOD / S&P KOD unavailable / 5.38% |
LoseKOD / S&P -34.04% / 5.12% |
| 2024-Q11/3 |
WinKOD / S&P 73.03% / 10.56% |
LoseKOD / S&P KOD unavailable / 5.71% |
LoseKOD / S&P -25.04% / 5.59% |
| 2023-Q41/3 |
WinKOD / S&P 68.89% / 11.69% |
LoseKOD / S&P KOD unavailable / 6.81% |
LoseKOD / S&P -22.38% / 7.78% |
| 2023-Q30/3 |
LoseKOD / S&P -73.91% / -3.27% |
LoseKOD / S&P KOD unavailable / 7.52% |
LoseKOD / S&P -24.27% / -5.03% |
| 2023-Q21/3 |
WinKOD / S&P 11.29% / 8.74% |
LoseKOD / S&P KOD unavailable / 9.50% |
LoseKOD / S&P -14.54% / -8.57% |
| 2023-Q11/3 |
LoseKOD / S&P -13.41% / 7.50% |
LoseKOD / S&P KOD unavailable / 10.77% |
WinKOD / S&P -1.66% / -15.69% |
| 2022-Q40/3 |
LoseKOD / S&P -7.49% / 7.56% |
LoseKOD / S&P KOD unavailable / 11.88% |
LoseKOD / S&P KOD unavailable / -17.99% |
| 2022-Q31/3 |
WinKOD / S&P 1.31% / -4.88% |
LoseKOD / S&P KOD unavailable / 13.47% |
LoseKOD / S&P KOD unavailable / -1.41% |
| 2022-Q21/3 |
WinKOD / S&P -1.04% / -16.10% |
LoseKOD / S&P KOD unavailable / 13.71% |
LoseKOD / S&P KOD unavailable / 11.04% |
| 2022-Q10/3 |
LoseKOD / S&P -90.89% / -4.60% |
LoseKOD / S&P KOD unavailable / 15.97% |
LoseKOD / S&P KOD unavailable / 42.23% |
| 2021-Q40/3 |
LoseKOD / S&P -11.67% / 11.03% |
LoseKOD / S&P KOD unavailable / 15.00% |
LoseKOD / S&P KOD unavailable / 96.40% |
| 2021-Q31/3 |
WinKOD / S&P 3.20% / 0.58% |
LoseKOD / S&P KOD unavailable / 10.77% |
LoseKOD / S&P KOD unavailable / 69.42% |
| 2021-Q20/3 |
LoseKOD / S&P -17.98% / 8.55% |
LoseKOD / S&P KOD unavailable / 6.58% |
LoseKOD / S&P KOD unavailable / 51.81% |
| 2021-Q10/3 |
LoseKOD / S&P -22.82% / 6.17% |
LoseKOD / S&P KOD unavailable / -1.06% |
LoseKOD / S&P KOD unavailable / 7.39% |
| 2020-Q41/3 |
WinKOD / S&P 148.12% / 12.15% |
LoseKOD / S&P KOD unavailable / -3.72% |
LoseKOD / S&P KOD unavailable / -33.42% |
| 2020-Q31/3 |
WinKOD / S&P 9.41% / 8.93% |
LoseKOD / S&P KOD unavailable / -2.04% |
LoseKOD / S&P KOD unavailable / -27.10% |
| 2020-Q20/3 |
LoseKOD / S&P 13.46% / 20.54% |
LoseKOD / S&P KOD unavailable / -0.46% |
LoseKOD / S&P KOD unavailable / -27.11% |
| 2020-Q10/3 |
LoseKOD / S&P -33.70% / -19.60% |
LoseKOD / S&P KOD unavailable / 3.47% |
LoseKOD / S&P KOD unavailable / -14.75% |
| 2019-Q41/3 |
WinKOD / S&P 400.35% / 9.07% |
LoseKOD / S&P KOD unavailable / 5.36% |
LoseKOD / S&P KOD unavailable / 2.99% |
| 2019-Q31/3 |
WinKOD / S&P 22.91% / 1.70% |
LoseKOD / S&P KOD unavailable / 5.02% |
LoseKOD / S&P KOD unavailable / 0.21% |
| 2019-Q21/3 |
WinKOD / S&P 79.17% / 4.30% |
LoseKOD / S&P KOD unavailable / 6.64% |
LoseKOD / S&P KOD unavailable / 8.65% |
| 2019-Q10/3 |
LoseKOD / S&P -8.03% / 13.65% |
LoseKOD / S&P KOD unavailable / 8.12% |
LoseKOD / S&P KOD unavailable / 14.29% |
| 2018-Q40/3 |
LoseKOD / S&P KOD unavailable / -13.52% |
LoseKOD / S&P KOD unavailable / 9.05% |
LoseKOD / S&P KOD unavailable / 18.23% |
| 2018-Q30/3 |
LoseKOD / S&P KOD unavailable / 7.71% |
LoseKOD / S&P KOD unavailable / 10.21% |
LoseKOD / S&P KOD unavailable / 19.06% |
| 2018-Q20/3 |
LoseKOD / S&P KOD unavailable / 3.43% |
LoseKOD / S&P KOD unavailable / 9.03% |
LoseKOD / S&P KOD unavailable / 14.46% |
| 2018-Q10/3 |
LoseKOD / S&P KOD unavailable / -0.76% |
LoseKOD / S&P KOD unavailable / 7.68% |
LoseKOD / S&P KOD unavailable / 12.46% |
| 2017-Q40/3 |
LoseKOD / S&P KOD unavailable / 6.64% |
LoseKOD / S&P KOD unavailable / 7.03% |
LoseKOD / S&P KOD unavailable / 13.82% |
| 2017-Q30/3 |
LoseKOD / S&P KOD unavailable / 4.48% |
LoseKOD / S&P KOD unavailable / 5.68% |
LoseKOD / S&P KOD unavailable / 17.57% |
| 2017-Q20/3 |
LoseKOD / S&P KOD unavailable / 3.09% |
LoseKOD / S&P KOD unavailable / 4.83% |
LoseKOD / S&P KOD unavailable / 17.74% |
| 2017-Q10/3 |
LoseKOD / S&P KOD unavailable / 6.07% |
LoseKOD / S&P KOD unavailable / 3.67% |
LoseKOD / S&P KOD unavailable / 13.32% |
| 2016-Q40/3 |
LoseKOD / S&P KOD unavailable / 3.82% |
LoseKOD / S&P KOD unavailable / 2.09% |
LoseKOD / S&P KOD unavailable / 7.05% |
| 2016-Q30/3 |
LoseKOD / S&P KOD unavailable / 3.85% |
LoseKOD / S&P KOD unavailable / 0.20% |
LoseKOD / S&P KOD unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | KOD total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 332.74% | 20.78% |
| Annualized return | 332.74% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | KOD total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -59.61% | 83.14% |
| Annualized return | -16.58% | 12.86% |
10Y · 2018-10-04 to 2026-08-27
| Metric | KOD total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 285.04% | 319.30% |
| Annualized return | 14.43% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |